Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin F(2α)

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 424-428

  Schnackenberg, Christine G ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Isoprostanes; Oxidative stress; Oxygen radicals; Superoxide dismutase

Indexed keywords

OXYGEN RADICAL; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY BLOOD FLOW; MEAN ARTERIAL PRESSURE; MEMBRANE PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 0032956654     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.424     Document Type: Article

References (41)

1. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1995; 44:363-368.
2. Harrison DG, Ohara Y. Physiologic consequences of increased vascular oxidative stress in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol. 1995;75:75B-81B.
3. McCord J. Oxygen-derived free radicals in postischemic tissue injury: mechanisms of disease. N Engl J Med. 1985;312:159-163.
4. Kitiyakara C, Wilcox C. Antioxidants for hypertension. Curr Opin Nephrol Hypertens. 1998;7:531-538.
5. Lacy F, O'Conner DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998;16:291-303.
6. Kumar DV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun. 1993;19:59-66.
7. Tse WY, Maxwell SR, Thomason H, Blann A, Thorpe GH, Waite M, Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens. 1994;89: 843-849.
8. Sehnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
9. Yoshioka M, Aoyama K, Matsushita T. Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats. Int J Vitam Nutr Res. 1985;55:301-307.
10. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inque M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:10045-10048.
11. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, Schmid-Schonoein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1998;95:4754-4759.
12. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 1995;25: 1083-1089.
13. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26:854-857.
14. Cosentino F, Patton S, D'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest. 1998;101: 1530-1537.
15. Roberts LJ, Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta. 1997;1345:121-135.
16. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J Clin Invest. 1992;90:2505-2507.
17. 2α in humans. J Biol Chem. 1996;271:20617-20620.
18. 2 receptors J Clin Invest 1992;90:136-141.
19. Iannone A, Bini A, Swartz HM, Tomasi A, Vannini V. Metabolism in rat liver microsomes of the nitroxide spin probe tempol. Biochem Pharmacol. 1989;38:2581-2586.
20. Nilsson UA, Olsson LI, Carlin G, Bylund-Fellenius AC. Inhibition of lipid peroxidation by spin labels: relationships between structure and function. J Biol Chem. 1989;19:11131-11135.
21. Gelvan D, Saltman P, Powell SR. Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci U S A. 1991;88: 4680-4684.
22. Karmeli F, Eliakim R, Okon E, Samuni A, Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut. 1995;37:386-393.
23. Mitchel JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russon A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimetic, tempol. Arch Biochem Biophys. 1991;289:62-70.
24. Welch WJ, Deng X, Snellen H, Wilcox CS. Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats. Am J Physiol. 1995;268:F175-F178.
25. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med. 1996;20:443-448.
26. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol. 1991;5:733-742.
27. Knowles RG, Moncada S. Mammalian nitric oxide synthase. Biochem J. 1994;298:249-258.
28. Pou S, Ou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992; 267:24173-24176.
29. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;15:170-179.
30. Halliwell B, Rootveld M. The measurement of free radical reactions in humans: some thoughts for the future. FEBS Lett. 1987;213:9-14.
31. 2-isoprostane regioisomers formed in vivo in the rat. Free Radic Biol Med. 1997;23:943-954.
32. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA. Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci. 1996;91:711-718.
33. Salahudeen A, Kanji V. Vitamin E suppresses cyclosporine-induced increase in the urinary excretion of arachidonic acid (AA) metabolites. J Am Soc Nephrol. 1997;8:A2831.
34. Salahudeen A, Kanji V. Rhabdomyolysis induces increase in the urinary excretion of vasoconstrictive arachidonic acid peroxidation products. J Am Soc Nephrol. 1997;8:A2771.
35. Holt S, Marley R, Fernando B, Harry D, Anand R, Goodier D, Roberts LJ II, Moore K. Renal dysfunction and oxidative stress following bile duct ligation. J Am Soc Nephrol. 1997;8:A2737.
36. Guidet BR, Shah V. In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Am J Physiol. 1989;256:F158-F164.
37. Yoshioka T, Bills T, Moore-Jarrett T, Green HL, Burr IM, Ichikawa J. Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int. 1990;38:282-288.
38. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension. 1998; 31:1248-1254.
39. Welch WJ, Tojo A, Lee J, Kang DG, Schnackenberg CG, Wilcox CS. NOS in JGA of SHR: expression and role of TGF. J Am Soc Nephrol. 1997;8:A1433.
40. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264:C1619-C1624.
41. 2α on retinal vessels. Am J Physiol. 1998;274:R1406-R1416.